📰 Nasdaq Amph News
Page 5 - Nasdaq Amph News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Amph. Real-time updates on events, politics, business and more.
May 14, 2023
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) was the recipient of a significant growth in short interest during the month of April. As of April 30th, there was short interest totalling 1,860,000 shares, a growth of 29.2% from the April 15th total of 1,440,000 shares. Approximately 5.3% of the company’s stock are sold short. Based […]
May 14, 2023
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) was the target of a large growth in short interest in April. As of April 30th, there was short interest totalling 1,860,000 shares, a growth of 29.2% from the April 15th total of 1,440,000 shares. Currently, 5.3% of the shares of the stock are short sold. Based on […]
May 10, 2023
Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) were up 8.9% on Wednesday . The company traded as high as $39.87 and last traded at $39.70. Approximately 317,490 shares traded hands during mid-day trading, an increase of 3% from the average daily volume of 309,719 shares. The stock had previously closed at $36.44. Wall […]
May 9, 2023
SG Americas Securities LLC lifted its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) by 138.8% during the 4th quarter, HoldingsChannel reports. The fund owned 10,588 shares of the company’s stock after purchasing an additional 6,154 shares during the period. SG Americas Securities LLC’s holdings in Amphastar Pharmaceuticals were worth $297,000 at […]
April 22, 2023
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) was the target of a large drop in short interest in the month of March. As of March 31st, there was short interest totalling 1,310,000 shares, a drop of 10.3% from the March 15th total of 1,460,000 shares. Based on an average trading volume of 286,100 shares, the […]
April 19, 2023
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) CFO William J. Peters sold 5,632 shares of Amphastar Pharmaceuticals stock in a transaction that occurred on Monday, April 17th. The stock was sold at an average price of $42.35, for a total transaction of $238,515.20. Following the transaction, the chief financial officer now directly owns 105,148 shares […]
April 17, 2023
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) reached a new 52-week high during trading on Monday . The stock traded as high as $42.35 and last traded at $41.72, with a volume of 41301 shares changing hands. The stock had previously closed at $42.15. Analyst Upgrades and Downgrades Separately, StockNews.com upgraded Amphastar Pharmaceuticals from a […]
April 14, 2023
Anfield Capital Management LLC raised its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) by 67.3% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,027 shares of the company’s stock after buying an additional 413 shares during the quarter. Anfield […]
April 14, 2023
Anfield Capital Management LLC lifted its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) by 67.3% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 1,027 shares of the company’s stock after acquiring an additional 413 shares during the quarter. Anfield Capital Management LLC’s holdings in Amphastar Pharmaceuticals were worth $29,000 […]
April 13, 2023
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) EVP Yakob Liawatidewi sold 5,000 shares of the stock in a transaction on Monday, April 10th. The shares were sold at an average price of $40.00, for a total transaction of $200,000.00. Following the transaction, the executive vice president now directly owns 69,215 shares in the company, valued […]